Cite
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
MLA
Katarzyna Jozwiak, et al. “Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.” Journal of the National Cancer Institute, vol. 108, no. 11, Dec. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....19334a130e1d0ba0c42005b4a6bbe5f9&authtype=sso&custid=ns315887.
APA
Katarzyna Jozwiak, Manel Esteller, Julian R. de Ruiter, Catia Moutinho, Ian J. Majewski, Karen Duran, Michiel de Maaker, Frans B. L. Hogervorst, Markus J. van Roosmalen, Edwin Cuppen, Esther H. Lips, Nicholas C. Turner, Ute Boon, Petra ter Brugge, Eline van der Burg, Lennart Mulder, Wigard P. Kloosterman, Heidrun Gevensleben, Jos Jonkers, … Jelle Wesseling. (2015). Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer. Journal of the National Cancer Institute, 108(11).
Chicago
Katarzyna Jozwiak, Manel Esteller, Julian R. de Ruiter, Catia Moutinho, Ian J. Majewski, Karen Duran, Michiel de Maaker, et al. 2015. “Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.” Journal of the National Cancer Institute 108 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....19334a130e1d0ba0c42005b4a6bbe5f9&authtype=sso&custid=ns315887.